Expression of FZD6 inversely correlates with miR-125b/miR-20b and TCF4 levels, and combined expression levels of miR-20b/-125b, with either FZD6 or TCF4, effectively predict GBM patients' survival. Here, FZD6 is linked to glioblastoma.